Press Releases May 14, 2026 09:13 AM

Diana Shipping Inc. Announces the Date for the 2026 First Quarter Financial Results, Conference Call and Webcast

Diana Shipping Inc. schedules first quarter 2026 financial results release and conference call for May 28, 2026.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
DSX

Diana Shipping Inc., a global dry bulk vessel operator, announced that it will release its first quarter 2026 financial results on May 28, 2026, prior to U.S. market open. The company will host a conference call and webcast to discuss the results and provide an investor presentation. Access details and replays will be available through the company website and telephone.

Diana Shipping Inc. Announces the Date for the 2026 First Quarter Financial Results, Conference Call and Webcast
DSX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Scheduled release of Q1 2026 financial results on May 28, 2026.
  • Conference call and webcast planned for management to discuss financial results.
  • Company operates dry bulk vessels focusing on iron ore, coal, grain, and other bulk commodities.
  • Key impacted sectors include maritime shipping, global trade, and commodity transportation.

ATHENS, Greece, May 14, 2026 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that its financial results for the first quarter ended March 31, 2026 are scheduled to be released before the opening of the U.S. financial markets on Thursday, May 28, 2026.

The Company’s management will conduct a conference call and simultaneous Internet webcast to review these results at 9:00 A.M. (Eastern Time) on Thursday, May 28, 2026.

Investors may access the webcast by visiting the Company’s website at www.dianashippinginc.com, and clicking on the webcast link. An accompanying investor presentation also will be available via the webcast link and on the Company’s website. The conference call also may be accessed by telephone by dialing 1-877-407-8291 (for U.S.-based callers) or 1-201-689-8345 (for international callers), and asking the operator for the Diana Shipping Inc. conference call.

A replay of the webcast will be available soon after the completion of the call and will be accessible for 30 days on www.dianashippinginc.com. A telephone replay also will be available for 30 days by dialing 1-877-660-6853 (for U.S.-based callers) or 1-201-612-7415 (for international callers), and providing the Replay ID number 13760464.

About the Company

Diana Shipping Inc. is a global provider of shipping transportation services through its ownership and bareboat charter-in of dry bulk vessels. The Company’s vessels are employed primarily on short to medium-term time charters and transport a range of dry bulk cargoes, including such commodities as iron ore, coal, grain and other materials along worldwide shipping routes.

Corporate Contact:
Margarita Veniou 
Chief Corporate Development, Governance & 
Communications Officer and Board Secretary 
Telephone: + 30-210-9470-100 
Email: mveniou@dianashippinginc.com
Website: www.dianashippinginc.com
X: @Dianaship

Investor Relations/Media Contact:
Nicolas Bornozis / Daniela Guerrero 
Capital Link, Inc. 
230 Park Avenue, Suite 1540 
New York, N.Y. 10169 
Tel.: (212) 661-7566 
Email: diana@capitallink.com


Risks

  • Uncertainties related to market demand for dry bulk shipping services which affects revenue recognition.
  • Potential volatility in global commodity trade routes impacting vessel utilization.
  • Dependence on short to medium-term charter contracts which may fluctuate with economic conditions impacting the shipping sector.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026